Stempoint Capital’s GH Research GHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.58M Buy
+195,143
New +$5.42M 0.82% 38
2025
Q4
– Sell
-545,275
Closed -$7.8M – 96
2025
Q3
$7.8M Buy
545,275
+444,449
+441% +$6.22M 1.56% 18
2025
Q2
$1.23M Buy
+100,826
New +$1.11M 0.39% 43

Other funds holding GHRS

Stempoint Capital's GHRS Position: Q3 2026 in Review

Stempoint Capital opened a new position in GH Research (GHRS) in Q3 2026: 195,143 shares worth $4.58M. The stake represents 0.82% of the portfolio and ranks #38 among its holdings. This is a return to the name: Stempoint Capital previously reported a position in GHRS as recently as Q3 2025.

Stempoint Capital first reported a position in GHRS in Q2 2025 and has held it in 3 quarters since. The position peaked at $7.8M in Q3 2025. 80 funds tracked by Wall St. Rank hold GHRS as of Q3 2026.

  • Stempoint Capital held 195,143 shares of GH Research worth $4.58M as of Q3 2026.
  • GH Research was a new Stempoint Capital position in Q3 2026.
  • GH Research made up 0.82% of Stempoint Capital's portfolio in Q3 2026, its #38 holding.
  • Stempoint Capital first reported a position in GH Research in Q2 2025 and has held it in 3 quarters since.
  • Stempoint Capital's GH Research position peaked at $7.8M in Q3 2025.
  • 80 funds tracked by Wall St. Rank held GH Research as of Q3 2026.

Based on Stempoint Capital's 13F filing for Q3 2026, filed 16 Nov 2026.